These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 19406268

  • 1. Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension.
    Khaleghi M, Al-Omari MA, Kondragunta V, Morgenthaler NG, Struck J, Bergmann A, Mosley TH, Kullo IJ.
    Am J Cardiol; 2009 May 01; 103(9):1255-60. PubMed ID: 19406268
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertension.
    Al-Omari MA, Khaleghi M, Mosley TH, Turner ST, Morgenthaler NG, Struck J, Bergmann A, Kullo IJ.
    Am J Hypertens; 2009 Aug 01; 22(8):860-6. PubMed ID: 19424162
    [Abstract] [Full Text] [Related]

  • 7. Biomarkers associated with pulse pressure in African-Americans and non-Hispanic whites.
    Coutinho T, Turner ST, Mosley TH, Kullo IJ.
    Am J Hypertens; 2012 Feb 01; 25(2):145-51. PubMed ID: 22012208
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Haemostatic markers are associated with measures of vascular disease in adults with hypertension.
    Khaleghi M, Singletary LA, Kondragunta V, Bailey KR, Turner ST, Mosley TH, Kullo IJ.
    J Hum Hypertens; 2009 Aug 01; 23(8):530-7. PubMed ID: 19190656
    [Abstract] [Full Text] [Related]

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
    Rubattu S, Barbato A, Marchitti S, Iacone R, Di Castro S, Evangelista A, Stanzione R, Ippolito R, Sciarretta S, Palmieri L, Volpe M, Strazzullo P, Olivetti Heart Study Research Group.
    J Hypertens; 2010 Aug 13; 28(8):1638-45. PubMed ID: 20453667
    [Abstract] [Full Text] [Related]

  • 14. Plasma C-terminal pro-endothelin-1 is associated with left ventricular mass index and aortic root diameter in African-American adults with hypertension.
    Al-Omari MA, Khaleghi M, Mosley TH, Morgenthaler NG, Struck J, Bergmann A, Kullo IJ.
    J Hum Hypertens; 2011 Feb 13; 25(2):106-13. PubMed ID: 20182452
    [Abstract] [Full Text] [Related]

  • 15. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
    Bernasconi M, Tamm M, Bingisser R, Miedinger D, Leuppi J, Müller B, Christ-Crain M, Stolz D.
    Chest; 2011 Jul 13; 140(1):91-99. PubMed ID: 21106656
    [Abstract] [Full Text] [Related]

  • 16. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ, Dhillon O, Kelly D, Squire IB, Struck J, Quinn P, Morgenthaler NG, Bergmann A, Davies JE, Ng LL.
    J Am Coll Cardiol; 2008 May 13; 51(19):1857-64. PubMed ID: 18466800
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
    Fischer M, Katan M, Morgenthaler NG, Seiler M, Müller B, Lackner P, Errath M, Helbok R, Pfausler B, Beer R, Schmutzhard E, Broessner G.
    Cerebrovasc Dis; 2014 May 13; 37(2):128-33. PubMed ID: 24481415
    [Abstract] [Full Text] [Related]

  • 19. Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Elmas E, Doesch C, Fluechter S, Freundt M, Weiss C, Lang S, Kälsch T, Haghi D, Papassotiriou J, Kunde J, Schoenberg SO, Borggrefe M, Papavassiliu T.
    Int J Cardiovasc Imaging; 2011 Apr 13; 27(4):547-56. PubMed ID: 20872251
    [Abstract] [Full Text] [Related]

  • 20. Association of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease.
    Ali Z, Sarcia P, Mosley TH, Kondragunta V, Kullo IJ.
    Vasc Med; 2009 Aug 13; 14(3):215-20. PubMed ID: 19651670
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.